Beta Finch - S&P 100 - EN

More earnings analysis: https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL)
──────────
**BETA FINCH PODCAST SCRIPT**

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into TJX Companies' fourth quarter 2026 results. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, TJX just delivered what CEO Ernie Herrman called an "excellent" quarter with some pretty impressive numbers.

JORDAN: Absolutely, Alex. The off-price retail giant crushed expectations across the board. Fourth quarter sales hit $17.7 billion, up 9% year-over-year, while comparable store sales grew a very strong 5%. That's on top of a 5% comp increase last year, so we're talking about solid momentum here.

ALEX: And the bottom line looked even better. Adjusted earnings per share came in at $1.43, up 16% from $1.23 last year and well above their plan. For the full year, they crossed a major milestone - net sales surpassed $60 billion for the first time, reaching $60.4 billion.

JORDAN: What I found particularly impressive was the breadth of their success. Every single division delivered comp sales growth of 4% or better. Marmaxx, their largest division, grew 4% to $36.6 billion in annual sales. HomeGoods hit its own milestone, surpassing $10 billion in annual sales with a strong 5% comp increase. And their international operations showed real strength - TJX Canada posted an outstanding 7% comp growth.

ALEX: Speaking of profitability, their adjusted gross margin expanded 60 basis points to 31.1% in Q4, driven primarily by higher merchandise margins. CFO John Klinger highlighted that shrink is now essentially back to pre-COVID levels after two consecutive years of 20 basis point improvements.

JORDAN: That shrink improvement is huge, Alex. It shows their operational excellence and suggests they've successfully navigated the inventory challenges that plagued many retailers. What's also interesting is their inventory strategy - balance sheet inventory was up 14%, but they frame this as a positive, with outstanding merchandise availability giving them tremendous buying flexibility.

ALEX: Let's talk about their growth strategy because Herrman was quite bullish about playing offense. He outlined several key initiatives - more aggressive marketing campaigns, including new campaigns for HomeGoods and TJ Maxx, deeper vendor relationships, and continued store remodels and new prototypes to enhance the shopping experience.

JORDAN: The vendor relationship piece is fascinating. They now work with approximately 21,000 vendors through their team of over 1,400 buyers. Herrman mentioned they're being more aggressive than ever in going after brands, particularly as some competitors face closures or disruptions. He said vendors are essentially giving them first call on excess inventory because of their reputation for being straightforward and paying on time.

ALEX: And the expansion story continues. They're planning to add 146 net new stores in fiscal 2027, including their first five stores in Spain. Long-term, they see potential for 7,000 stores globally with existing banners in current countries plus Spain - that's about 1,700 more stores than they have today.

JORDAN: But let's talk about the guidance, which was a bit more conservative. For fiscal 2027, they're projecting comp sales growth of 2% to 3%, total sales of $62.7 to $63.3 billion, and earnings per share of $4.93 to $5.20. That EPS range represents 4% to 6% growth, which is solid but notably more modest than recent performance.

ALEX: During the Q&A, there were some interesting insights. When asked about pricing actions, Herrman explained their flexible approach - they don't dictate retail prices but rather maintain approp

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: HEALTHCARE (https://betafinch.com/groups/HEALTHCARE)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! Today we're digging into Stryker's Q2 2026 results — and this is a good one, because it's really a comeback story.

But first — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Okay, so context matters a lot here. Stryker got hit by a cybersecurity incident that knocked out manufacturing for about a month in Q1. So Q2 is really the "how fast can they recover" quarter.

ALEX: And the answer is — pretty fast. Organic sales growth of 9%, adjusted EPS of $3.69, up almost 18% year over year. For a $25 billion company that had plants offline for weeks, that's a strong number.

JORDAN: Right, CEO Kevin Lobo actually said it himself on the call — growing around 9% "given that we were knocked out for almost an entire month" is a pretty good outcome. And you saw strength pretty much everywhere: MedSurg and Neurotechnology up over 9%, Orthopedics up 8.6%. U.S. trauma and extremities grew over 12%, medical devices — Sage, Emergency Care — grew north of 13%.

ALEX: The one soft spot was peripheral vascular, down almost 7% in the U.S. There was a supply disruption at one of their Inari manufacturing plants that caused a real backorder problem. They actually had to ration product to their best customers.

JORDAN: Which is a rough thing to say out loud on an earnings call, but at least it's honest. Management expects that backorder to work itself down to manageable levels by the end of Q3, and they're still bullish long-term on that business — especially with the AVS acquisition that just closed, which adds an IVL, intravascular lithotripsy, product to the portfolio.

ALEX: Let's talk strategy for a second, because there were some real headline moments here. Mako, their robotics platform, just turned 20 years old, and they had their best-ever second quarter for Mako installations, both in the U.S. and internationally. Over 2.5 million procedures done globally now, systems in 47 countries.

JORDAN: And the bigger story is the full commercial launch of Mako RPS — that's their handheld robotics system. It's aimed at surgeons who aren't ready to commit to a full Mako cart, especially in ambulatory surgery centers doing total knees. Lobo said the haptic feedback is what's really wowing surgeons — that you can get that kind of precision in a handheld device.

ALEX: They're also rolling out Triathlon Gold, a new insert for their knee system, a new total ankle replacement called Encompass, and a trauma plating system called Pangaea that's launching in Europe. So despite the manufacturing hit, the product pipeline didn't really slow down.

JORDAN: Now, the money question everyone on the call kept circling back to — capital equipment. Stryker's sitting on an elevated order backlog because demand outpaced their ability to produce during the recovery. Beds, in particular — their ProCuity hospital bed business — has huge order volume they just haven't been able to fill yet.

ALEX: And management's plan is straightforward: add manufacturing shifts and grind through the backlog in the second half of the year. Lobo was pretty confident about this, saying these aren't new products, this is stuff they know how to make — it's purely an execution and capacity question, not a demand question.

JORDAN: That came up a lot in the Q&A, actually — analysts pushing hard on whether Stryker can really hit an implied 11% organic growth rate in the back half to reach their guidance midpoint. Lobo's response was basically, "we raised the low end of our guidance from 8% to 8.3%, that alone should tell you how confident we are."

ALEX: On guidance — they narrowed the full-year range. O

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: HEALTHCARE (https://betafinch.com/groups/HEALTHCARE)
──────────
**Beta Finch Podcast Script - Stryker Q1 2026 Earnings**

---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from corporate America's quarterly reports. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Stryker's Q1 2026 results, and wow, this was definitely not your typical earnings call.

**ALEX:** Before we get into it, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. So Alex, let's start with the elephant in the room - Stryker got hit by a cyberattack late in Q1. How bad was the damage?

**ALEX:** It was significant, Jordan. Organic sales growth came in at just 2.4% - way below what you'd normally expect from Stryker. Even more telling, adjusted earnings per share dropped 8.5% to $2.60. CEO Kevin Lobo mentioned they had 40,000 laptops wiped and were essentially shut down for about three weeks.

**JORDAN:** That's brutal. But here's what caught my attention - despite all this chaos, they maintained their full-year guidance. That's either incredibly optimistic or they have serious confidence in their recovery plan.

**ALEX:** I'm leaning toward confidence. CFO Preston Wells was pretty detailed about why they think they'll bounce back. He explained that different business units were affected differently based on their operating models. For example, their orthopedic business has a lot of consigned inventory sitting right at hospitals, so surgeries could continue even when Stryker's systems were down.

**JORDAN:** Right, it was more of a revenue recognition issue there rather than lost procedures. But their capital equipment business - things like hospital beds and defibrillators - that's where they really got hit because those are made-to-order products.

**ALEX:** Exactly. And Wells said most of that lost production will shift to Q3 and Q4 rather than Q2, which makes sense given manufacturing lead times. What I found interesting was how resilient their underlying business seems to be.

**JORDAN:** Talk about that resilience - what are the bright spots?

**ALEX:** Well, they had their best-ever Q1 for Mako robot installations, both in the US and internationally. That's their surgical robotics platform, and utilization rates are climbing. Plus they just got European approval for Pangaea - that's their trauma plating system that's been driving explosive growth in the US.

**JORDAN:** And let's not forget the M&A activity. They announced they're acquiring Amplitude Vascular Systems, which gets them into the intravascular lithotripsy space. That's basically using sound waves to break up calcified plaque in blood vessels.

**ALEX:** Kevin Lobo was really bullish on that deal during the Q&A. He said it fits perfectly with their existing peripheral vascular business through Inari, which they bought last year. Same call points, same physicians.

**JORDAN:** Speaking of the Q&A, there were some great nuggets in there. One analyst asked about competitive dynamics in orthopedics, and Lobo basically said "bring it on." He mentioned they expect to keep outgrowing the orthopedic market by 200 to 300 basis points, just like they have been.

**ALEX:** I loved his comment about their robotics portfolio too. He said the new Mako RPS - that's their handheld robotic system - is getting great feedback, especially in ambulatory surgery centers. It's like a stepping stone for surgeons who find full Mako too intimidating.

**JORDAN:** The international story is pretty compelling too. While the US grew 1.9%, international was up 3.9% despite the cyber issues. Lobo highlighted Japan as thei

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: HEALTHCARE (https://betafinch.com/groups/HEALTHCARE)
──────────
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you the insights that matter. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into Stryker's Q4 2025 earnings - and folks, this medical device giant just delivered what CEO Kevin Lobo called "outstanding results" across all key metrics.

**ALEX**: Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now Alex, let's talk numbers because Stryker really brought the heat this quarter.

**ALEX**: They sure did, Jordan. Stryker crushed it with 11% organic sales growth in Q4, hitting over $25 billion in sales for the full year. That's their fourth consecutive year of double-digit organic growth. And here's what I love - they managed 10.3% growth for the full year against a tough 10.2% comparable from 2024.

**JORDAN**: The consistency is remarkable. And it wasn't just the top line - adjusted earnings per share jumped 11.5% to $4.47 in the quarter, with full-year EPS up 11.8% to $13.63. What really stands out to me is they achieved this while managing $400 million in tariff headwinds, including an incremental $200 million hit they're expecting in 2026.

**ALEX**: That tariff management is impressive. Preston Wells, their CFO, mentioned they're absorbing these costs while still driving meaningful operating margin expansion. Speaking of which, they delivered their second consecutive year of at least 100 basis points of margin expansion. That shows real operational muscle.

**JORDAN**: Let's break down the business segments because there were some real standouts. MedSurg and Neurotechnology posted 12.6% organic growth, with U.S. growth hitting 13%. The instruments business was particularly hot with 19.1% U.S. growth driven by strong capital demand.

**ALEX**: And then there's the Mako story - which honestly feels like the star of this whole show. Jordan, they had another record quarter for Mako installations, both in the U.S. and worldwide. Their installed base now includes over 3,000 Mako systems globally.

**JORDAN**: The Mako 4 transition has been what Lobo called "an absolute home run." Here's a stat that blew me away - over two-thirds of their knee procedures and over one-third of hip procedures in the U.S. are now performed on Mako. One surgeon even told Lobo that the new revision hip application was like a "cheat code" for difficult procedures.

**ALEX**: That's incredible feedback. And they're not stopping there - they're expanding Mako into shoulder applications mid-year, plus they just started cases on their handheld robot called Mako RPS. This is designed for surgeons who want robotic assistance but aren't ready for the full Mako system complexity.

**JORDAN**: The RPS launch is smart positioning. It sits between their manual instruments and full Mako systems, potentially opening up new customer segments, especially in ambulatory surgery centers. Speaking of ASCs, they mentioned hips and knees are now in the high teens percentage flowing through that channel.

**ALEX**: Let's talk guidance because this is where Stryker shows confidence in their momentum. For 2026, they're guiding 8% to 9.5% organic sales growth and adjusted EPS of $14.90 to $15.10. That top end of the range is slightly higher than where they started 2025, which Lobo says reflects their elevated capital backlog and strong procedural outlook.

**JORDAN**: And here's something interesting from the Q&A - when asked if 10% growth was still possible, Lobo said "certainly possible" for their fifth consecutive year of double-digit growth. The confidence s

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown of the companies moving the markets. I'm Alex, joined as always by Jordan. Today we're digging into S&P Global's second quarter 2026 results.

JORDAN: Big one — first call since the Mobility spin closed.

ALEX: Exactly, but before we get into it — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Good context to keep in mind, especially with a report this dense.

ALEX: So let's start with the headline numbers. Revenue grew 11% year-over-year, adjusted EPS jumped 23%, and margins expanded 200 basis points to 54.3%. CEO Martina Cheung called this her first call since completing the Mobility spin-off on July 1st, and she framed the quarter around four core divisions now: Ratings, Indices, Energy, and Market Intelligence.

JORDAN: And the star of the show was really the "benchmarks" businesses — Ratings, Indices, and the Platts side of Energy. Those grew 15% collectively and now make up more than 80% of operating profit, even though they're "only" two-thirds of revenue. That's a really profitable core.

ALEX: Let's talk Ratings first, because it had a record quarter — revenue up 17%. Bond issuance was up 25%, driven by AI infrastructure and data center buildout, plus M&A activity.

JORDAN: That hyperscaler number really stood out to me. They initially guided for about $200 billion in hyperscaler-related issuance this year. In just the first half, they already saw $169 billion. They've now bumped full-year guidance up to $250-300 billion.

ALEX: That's a massive raise. And CFO Eric Aboaf made a point of saying this outperformance isn't cannibalizing future refinancing — they're still looking at roughly $11 trillion of rated debt coming due for refinancing over the next four and a half years.

JORDAN: Indices was arguably even stronger — 20% revenue growth, 13 straight record quarters. ETF assets tied to S&P Dow Jones hit $6.35 trillion, and one S&P 500-linked ETF became the first ever to cross $1 trillion in AUM.

ALEX: Now, not everything was rosy. Energy only grew 3%, and management was upfront that the Iran conflict has been messing with contract renewals and trading volumes. They're calling it transitory, expecting growth to normalize back to that 6-8% range next year.

JORDAN: And Market Intelligence — the segment everyone's watching for a turnaround story — grew a more modest 6%. They just restructured it into two lines: Kensho Data, which is the high-growth AI and proprietary data piece, and Platforms, the more mature legacy tools like CapIQ. There was also mention of some "subscale" products in consulting and sustainability dragging on growth, and Cheung didn't rule out shedding those down the road.

ALEX: The AI angle was everywhere on this call, honestly. Their Kensho LLM-ready API client base is now over 500 and grew 70% quarter-over-quarter, with API call volume up 5x sequentially.

JORDAN: What I found interesting in the Q&A was how they're thinking about monetizing that. Eric Aboaf described it as a mix of consumption-based pricing and additional dataset fees, basically capturing value as clients pull more data through AI tools rather than just charging flat subscription fees.

ALEX: There was also a question about elongated sales cycles with big clients, and Martina actually framed that as a positive — she said the conversations are getting more complex because clients want to do more with their data and AI, and S&P is being deliberate about protecting its IP in those negotiations.

JORDAN: On the capital return side, this is a big deal for shareholders — they raised the 2026 buyback target by nearly $3 billion, to more than $7 billion for the full year. That's over 5% of their current ma

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
──────────
**BETA FINCH PODCAST SCRIPT**

---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into S&P Global's first quarter 2026 results. This one's particularly interesting given the backdrop of geopolitical tensions and the company's aggressive AI push.

Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, S&P Global just reported some pretty solid numbers despite what CEO Martina Cheung called an "incredibly volatile and dynamic operating environment." Walk us through the headline numbers.

**JORDAN**: Absolutely, Alex. These results really showcase the resilience of S&P Global's business model. They posted 10% revenue growth year-over-year, with 9% organic constant currency growth. What really caught my eye was the 14% jump in adjusted diluted EPS and 140 basis points of margin expansion on a trailing twelve-month basis. That's impressive operating leverage.

**ALEX**: And they returned a billion dollars to shareholders through share repurchases alone, on top of dividends. But let's talk about the elephant in the room - this Iranian conflict that's been disrupting energy markets. How did that impact their different divisions?

**JORDAN**: Great question. The conflict created this interesting tale of two cities within S&P Global. On one hand, their Energy division faced direct headwinds - they actually lowered their full-year guidance for that segment by a full percentage point to 4.5% to 6% organic growth. CEO Cheung mentioned that some Middle Eastern energy customers had facilities directly impacted, and supply chain disruptions are expected to persist through the second quarter.

But here's what's fascinating - this volatility actually benefited other parts of the business. Their Ratings division saw 13% revenue growth, partly driven by what they called "hyperscaler" issuance - basically big tech companies issuing debt for AI infrastructure investments.

**ALEX**: That's a perfect segue into what I think is the real story here - S&P Global's AI transformation. Jordan, they're not just talking about using AI internally; they're fundamentally changing how customers access their data. Can you break down this strategy?

**JORDAN**: This is where it gets really interesting, Alex. S&P Global is essentially becoming an AI-native data company. They're making their data accessible through what they call "model context protocol" - basically allowing customers to use S&P data directly within AI platforms like Claude and ChatGPT.

The numbers they shared are eye-popping. API call volumes were 5x higher in Q1 versus just one quarter earlier, and doubled month-over-month from February to March alone. They now have over 300 customers either contracted or in trial periods for their AI-ready APIs.

**ALEX**: And they're seeing real pricing power from this AI integration, right?

**JORDAN**: Exactly. This is where the monetization story gets compelling. During the quarter, two financial clients opted to pay 35% to 45% premium increases just to get their data in AI-ready formats. CFO Eric Aboaf mentioned that customers using their AI solutions are showing much higher growth rates - 30% higher in Market Intelligence and double the growth rate in Energy compared to non-AI customers.

One example really stood out to me: they had a buy-side client working with their Kensho AI team who liked their AI plugin so much that they canceled their existing provider and switched to S&P Global, even though it was 20% more expensive.

**ALEX**: Let's talk about the guidance. They maintained most of their full-year outlook despite the geopolitical headwinds. What should investors ex

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
──────────
**Beta Finch Podcast Script: S&P Global Q4 2025 Earnings**

---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into S&P Global's Q4 2025 earnings call - and wow, what a year it's been for this financial data giant.

**ALEX**: Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now Alex, S&P Global really delivered some impressive numbers here. Let's start with the headline figures.

**ALEX**: They certainly did. Revenue grew 9% reported, 8% organic constant currency for Q4. For the full year, they hit the high end of their original guidance on revenue growth, margins, AND earnings per share. EPS grew 14% for the year, and get this - they returned 113% of adjusted free cash flow to shareholders.

**JORDAN**: That's a massive cash return. And speaking of returns, they just announced their 53rd consecutive year of dividend increases. Plus they repurchased over $5 billion in stock during 2025. But what really caught my attention was how CEO Martina Cheung framed their strategic vision.

**ALEX**: Right, she kept coming back to this concept of "advancing essential intelligence." Over 95% of their revenue is tied to proprietary benchmarks, differentiated data, and critical workflow tools. And Jordan, they expect that percentage to increase over time.

**JORDAN**: That's a key point because it speaks to their competitive moat, especially with all the AI disruption happening. Speaking of which, they made some fascinating comments about AI being a "net tailwind" for their business. They've launched AI products in every division and are seeing real customer adoption.

**ALEX**: The AI discussion was particularly interesting during the Q&A. With all the recent announcements from companies like Anthropic about financial services plugins, investors were clearly concerned about potential disruption to S&P's workflow products.

**JORDAN**: Martina's response was pretty compelling though. She emphasized that their workflow tools aren't just simple apps - they're enterprise-grade solutions that have been refined over years. Products like iLEVEL and Capital IQ Pro integrate deeply into regulated environments and provide mission-critical functionality that can't easily be replicated.

**ALEX**: And she mentioned something that I found particularly telling - customers are telling them they want fewer vendors, not more. They want S&P to embed the latest AI technology directly into their existing platforms rather than having to work with multiple providers.

**JORDAN**: Exactly. And they're seeing tangible results from their AI investments. For example, they deployed an automated data ingestion tool on iLEVEL, and within six months, nearly 20% of customers opted for that add-on feature. That's real revenue generation from AI enhancements.

**ALEX**: Now let's talk about their 2026 outlook because this is where things get really interesting for investors. They're guiding for 6% to 8% organic constant currency revenue growth, continued margin expansion, and 9% to 10% EPS growth.

**JORDAN**: But here's what's fascinating - they're being quite prudent about their market-driven businesses. For their Ratings division, they're expecting "Billed Issuance" - basically the debt they rate - to grow only low to mid-single digits. That's despite some pretty favorable conditions.

**ALEX**: Right, and CFO Eric Aboaf walked through their assumptions. They're expecting most 2026 debt refinancing to happen this year, but they're not counting on massive pull-forward from 2027 and 2028. They're also being conservative about M&A activity and hypersc

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: ENERGY (https://betafinch.com/groups/ENERGY)
──────────
WELCOME TO BETA FINCH — SOUTHERN COMPANY (SO) Q2 2026

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, joined as always by Jordan, and today we're digging into Southern Company's second quarter 2026 results. Before we get into it — quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: And Alex, this is a fun one — because Southern Company isn't just beating numbers this quarter, they're sitting at the center of the whole AI infrastructure buildout story. Data centers, hyperscalers, nuclear — it's all here.

ALEX: Let's start with the headline numbers. Adjusted EPS for Q2 came in at $1.13 per share — that's $0.21 higher than Q2 last year, and $0.13 above what they'd guided last quarter. First half of the year, adjusted EPS is $2.46, well ahead of expectations.

JORDAN: And because of that strength, management now expects full-year 2026 adjusted EPS to land near or at the top of their guidance range of $4.50 to $4.60. They also gave Q3 guidance of $1.65 a share. So they're not just beating — they're raising the bar for the rest of the year.

ALEX: What's actually driving this? CFO David Poroch pointed to increased usage and customer growth, higher AFUDC — that's allowance for funds used during construction, basically a return utilities earn while big projects are being built — plus earnings from equity investments and some favorable tax impacts.

JORDAN: The sales growth numbers are honestly the headline for me. Weather-normal retail electricity sales were up 2.3% year-to-date — the strongest growth through June in almost two decades. And get this: data center usage was up 55% compared to Q2 last year, and system-wide data center load now exceeds 1.2 gigawatts.

ALEX: That's the story everyone's watching right now — power demand from AI data centers. And Southern just landed a massive one. Georgia Power signed a 3.2 gigawatt, 25-year contract with OpenAI for a site near Savannah.

JORDAN: Twenty-five years, Alex. That's the kind of contract length that makes utility investors sit up. And it's not a standalone number — combined with three new projects in Alabama totaling about 3 gigawatts, Southern's total contracted large-load demand is now over 17 gigawatts through the mid-2030s.

ALEX: And the pipeline behind that is enormous — CEO Chris Womack said their prospective pipeline of large industrial and data center projects remains "well above 75 gigawatts," with another 8 gigawatts in late-stage development, 3 of which could finalize soon.

JORDAN: What I liked in the Q&A was how much attention they paid to protecting existing customers from this growth. Chris Womack talked about the National Ratepayer Protection Pledge they just joined, and the contract structure — minimum bills that cover 100% of the incremental cost to serve, plus serious collateral backing.

ALEX: That collateral detail was wild. On a question from Wolfe Research's Steve Fleishman, David Poroch clarified that across the full 17-gigawatt portfolio of large-load contracts, Southern's holding about $21 billion in collateral — lines of credit, surety bonds, parent guarantees — enough to keep their effective credit exposure around an A-minus or better, even when the counterparty itself isn't quite investment grade.

JORDAN: That's a smart risk-management story for a company taking on this much new, concentrated demand. And it's part of why they can say retail base rates are staying stable in Georgia and Alabama through 2029 — even as they're plugging in gigawatts of new load.

ALEX: The OpenAI deal also included something new — one gigawatt of flexible demand response, meaning OpenAI's site can dial back u

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: ENERGY (https://betafinch.com/groups/ENERGY)
──────────
**BETA FINCH PODCAST SCRIPT**

---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into Southern Company's Q1 2026 earnings call, and wow - this utility is absolutely crushing it in the data center boom.

**ALEX**: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. So Alex, let's start with the numbers because they're pretty impressive.

**ALEX**: They really are. Southern posted adjusted earnings per share of $1.32 for Q1, which was 9 cents higher than last year and beat their own estimate by 12 cents. That's solid execution right there.

**JORDAN**: What's driving this outperformance? Because utilities aren't exactly known for big earnings surprises.

**ALEX**: Here's where it gets interesting - it's all about load growth. Their weather-normal retail electricity sales jumped 2.3% year-over-year, which CEO Chris Womack called "the highest total retail sales growth that we have seen in the first quarter in recent history." But the real story is in the commercial segment.

**JORDAN**: Right, commercial sales were up 4.5% when adjusted for weather, and get this - data center usage alone was up 42% year-over-year. That's not a typo, folks. Forty-two percent.

**ALEX**: And they added 46,000 new residential customers to their system. The Southeast continues to be this massive economic magnet. In Q1 alone, they announced over $7 billion in capital investment and nearly 4,000 permanent jobs coming to their region.

**JORDAN**: The scale of what Southern is dealing with on the large load front is just staggering. They now have 11 gigawatts of fully contracted large load agreements - that's enough to power roughly 8 million homes. And in just the last two months, they signed contracts for another 1.9 gigawatts with hyperscalers.

**ALEX**: But here's what I love about their approach - these aren't your typical utility contracts. Every single large load customer has to cover their full share of costs to serve them. There are minimum bills, collateral requirements, cancellation fees. Southern isn't taking any risks here.

**JORDAN**: Smart structure. And the pipeline is enormous - they're talking about over 75 gigawatts in their prospective pipeline, with 12 gigawatts in late-stage discussions through the mid-2030s. Half of that 12 gigawatts is expected to be finalized with executed contracts in the near term.

**ALEX**: To put that in perspective, Jordan, Southern's entire current generating capacity is around 50 gigawatts. We're potentially talking about doubling their system over the next decade.

**JORDAN**: Which brings us to the infrastructure challenge. Georgia Power just launched an RFP - that's request for proposals - for 2 to 6 gigawatts of new dispatchable generation, including thermal, battery storage, and renewables, all coming online in 2032-2033.

**ALEX**: And they're not just planning - they're already building. They've got 10 gigawatts of new generation resources under development right now. Georgia Power just brought two new battery storage systems online, totaling nearly 200 megawatts of capacity.

**JORDAN**: The financial implications are massive too. CFO David Poroch mentioned that if they get selected for company-owned resources in these RFPs, we could be looking at about $2 billion of incremental capital expenditure per gigawatt. That's serious money.

**ALEX**: Speaking of money, they just secured something pretty remarkable - $26.5 billion in loan agreements with the Department of Energy. This is historic low-cost financing that's projected to save customers

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: BANKS (https://betafinch.com/groups/BANKS)
──────────
Welcome to Beta Finch, your AI-powered earnings breakdown of the numbers that matter, the stories behind them, and what it all means for you.

ALEX: Hey everyone, welcome back to Beta Finch! I'm Alex, here with Jordan, and today we're digging into Charles Schwab's Q2 2026 results — and Jordan, this one's got a headline number that jumped off the page.

JORDAN: It really did.

ALEX: Before we get into it, quick reminder — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Right, so let's start with the topline. Schwab posted $7.1 billion in total revenue, up 21% year-over-year, and adjusted EPS of $1.62 — that's a 42% jump from last year. That's not incremental growth, that's a genuinely strong quarter.

ALEX: And it wasn't just one line item carrying the load. Net interest revenue was up 19%, asset management fees up 16% to $1.8 billion, and trading revenue jumped 28% to $1.2 billion on 11.9 million daily average trades. That's a company firing on basically every cylinder.

JORDAN: What stood out to me is where that net interest strength is coming from. It's not just sitting on deposits and collecting spread passively — bank lending balances hit $67 billion, up 33% year-over-year, largely driven by their Pledged Asset Line product. Clients are borrowing against their portfolios instead of selling appreciated stock, which is a pretty clever way to deepen the relationship without pushing clients out of their positions.

ALEX: Yeah, CEO Rick Wurster made that point explicitly in the call — someone with a big embedded gain who wants access to cash, they don't want to sell and trigger taxes, so they pledge the assets instead. And apparently only about half a percent of Schwab clients use one of these lending products today, versus 4% industry-wide. So there's a long runway there.

JORDAN: That "lending penetration gap" language really jumped out at me. If they can even partially close that gap, it's a meaningful, durable growth lever — not a one-quarter sugar high.

ALEX: Let's talk client growth too, because the numbers there are big. 1.4 million new brokerage accounts in the quarter, $120 billion in core net new assets — up almost 50% year-over-year. And zooming out to the first half of the year, $2.7 million new accounts and $260 billion in net new assets.

JORDAN: And management reiterated they expect 5% or higher organic growth as the long-term target across their three businesses — Investor Services, Advisor Services, and the workplace/retirement business. Advisor Services in particular has been running above that, 6%-plus the last four quarters, as independent RIAs keep gaining share.

ALEX: There's also a strategic thread running through this call that I think is worth pulling on — Schwab really positioning itself as the "one-stop shop" for people's entire financial life. Wealth, banking, lending, trading, and now increasingly private markets and crypto.

JORDAN: Right, they closed the Forge acquisition for private markets access, they're piloting crypto transfers by the end of the month, and they made an investment in Paxos to support that crypto rollout. None of that is moving the needle financially yet — CFO Mike Verdeschi was upfront that these are smaller contributors for now — but it rounds out the platform.

ALEX: The wealth advice opportunity might actually be the bigger long-term story, though. Wurster pointed out the U.S. retail advice market is $37 trillion, and Schwab only has about 2% share. Only 5% of Schwab retail households are currently on a fee-based advice solution, even though 31% say they'd be willing to pay for advice.

JORDAN: And clients on their Schwab Wealth Advisory offer generate t

This episode includes AI-generated content.